|
Dana M. Gordon, Ph.D.
Partner
Registered Patent Attorney
Boston
Dr. Dana Gordon is the Deputy Chair of Foley Hoag's Intellectual Property Group. In that capacity he prepares and prosecutes U.S., international and foreign patent applications in the life sciences, including those that involve small molecules, pharmaceuticals, synthetic methods, molecular diversity, drug discovery, polymers, materials science, biochemistry, molecular biology and medical devices. He also prepares non-infringement, invalidity and clearance patent opinions.
Counseling on business management of intellectual assets, Dana advises leading universities, pharmaceutical companies, and medical device companies on strategic aspects of patent and trade secret protection. He also provides his clients with due diligence assessments of U.S., international, and foreign patent portfolios in connection with technology transactions.
Reflecting his doctorate in organic chemistry and his postgraduate chemistry fellowship at Harvard University, Dana has a substantial record of technical accomplishments in the life sciences. He directed an independent research program at Brandeis University focused on the synthesis of small molecule antagonists of retroviruses, multiple drug resistance in cancer and bacteria, and hypertension. His postdoctoral research focused on molecular recognition and self-assembly in solution, and the development and application of synthetic methods using organoindium reagents. Dana's doctoral research at Yale University focused on synthetic methods and the synthesis of biologically-relevant small molecule and carbohydrate natural products.
Bars and Court Admissions
Massachusetts
U.S. Patent & Trademark Office (Agency)
professional / civic involvement
American Chemical Society, Member
American Association for the Advancement of Science, Member
Association of University Technology Managers, Member
American Intellectual Property Law Association, Member
Boston Patent Law Association, Member
Boston Bar Foundation, Junior Fellow
American Bar Association
American Intellectual Property Law Association
Boston Patent Law Association
Intellectual Property Owners Association
Massachusetts Bar Association
Worcester Comprehensive Child Care Services, Board of Directors
SPEECHES AND CONFERENCES
Panelist, Venture Capital & IP/Tech Transfer, Harvard Medical School (April 2007)
Panelist, Law School for the CFO, Emerging Enterprise Center (April 2007)
Moderator, RNAi: Talking Out Loud About Gene Silencing, 5th Annual Mass. High Tech BioForum (February 2007)
publications
Proof of Purpose: The US Utility Requirement, EUROPEAN BIOPHARMACEUTICAL REVIEW, 32-33 (Spring 2006)
United States: Upjohn v. Mova Pharmaceutical, PATENT WORLD 128, 18-20 (December 2000/January 2001)
Dana M. Gordon et al., A Type 1 Intramolecular Diels-Alder Approach to the Mniopetals: Intervention of a Thermal [1,5] Hydrogen Shift, IND. J. CHEM. 38B, 269-273 (1999)
Dana M. Gordon et al., Total Synthesis of Endothelin-Converting Enzyme Antagonist WS75624 B., TETRAHEDRON LETT. 9335-9338 (1998)
Dana M. Gordon et al., Asymmetric Synthesis of Sesaminone: Confirmation of Its Structure and Determination of Its Absolute Configuration, J. ORG. CHEM. 62, 7413-7417 (1997)
Dana M. Gordon et al., Design and Synthesis of Hydrogen-bonded Aggregates. Theory and Computation Applied to Three Systems Based on the Cyanuric Acid-Melamine Lattice, TETRAHEDRON 51, 607 (1995)
Dana M. Gordon et al., Non-Covalent Synthesis: Using Physical-Organic Chemistry to Make Aggregates, ACC. CHEM. RES. 28, 37 (1995).
|
